Ultrastructural features and expression of cytoskeleton proteins of podocyte from patients with minimal change disease and focal segmental glomerulosclerosis

Renal Failure

Volumn 30, Issue 5, 2008, Pages 477-483

  Shi, Su Fang ^a   Wang, Su Xia ^a   Zhang, You Kang ^a   Zhao, Ming Hui ^a   Zou, Wan Zhong ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Cytoskeleton proteins; Immunogold labeling; Microscopy electron; Podocyte; Proteinuria

Indexed keywords

ALPHA ACTININ; CREATININE; CYTOSKELETON PROTEIN; SERUM ALBUMIN;

ADULT; ARTICLE; BLOOD PRESSURE; CELL ULTRASTRUCTURE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ELECTRON MICROSCOPY; FEMALE; FOCAL GLOMERULOSCLEROSIS; HUMAN; HUMAN TISSUE; IMMUNOELECTRON MICROSCOPY; IMMUNOGOLD LABELING; MALE; MINIMAL CHANGE GLOMERULONEPHRITIS; MORPHOMETRICS; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; STATISTICAL ANALYSIS;

ACTININ; CYTOSKELETAL PROTEINS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; MICROFILAMENTS; NEPHROSIS, LIPOID; PODOCYTES;

EID: 45749158598     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220802060497     Document Type: Article

References (27)

1. Braden GL, Mulhern JG, O'Shea MH, et al. Changing incidence of glomerular disease in adult. Am J Kidney Dis. 2000;35:878-883.
2. Conlon PJ, Butterly D, Albers F, et al. Clinical and pathologic features of familial focal segmental glomerulosclerosis. Am J Kidney Dis. 1995;26:34-40.
3. Kriz W, Kretzler M, Nagata M, et al. A frequent pathway to glomerulosclerosis: Deterioration of tuft architecture-podocyte damage-segmental sclerosis. Kidney Blood Press Res. 1996;19:245-253.
4. Kerjaschki D. Caught flat-footed: Podocyte damage and the molecular basis of focal glomerulosclerosis. J Clin Invest. 2001;108:1583-1587.
5. Yoshikawa N, Ito H, Akamatsu R, et al. Glomerular podocyte vacuolization in focal segmental glomerulosclerosis. Arch Pathol Lab Med. 1986;110:394-398.
6. Chiang ML, Hawkins EP, Berry PL, et al. Diagnostic and prognostic significance of glomerular epithelial cell vacuolization and podocyte effacement in children with minimal lesion nephrotic syndrome and focal segmental glomerulosclerosis: An ultrastructure study. Clin Nephrol. 1988;30:8-14.
7. Lahdenkari A, Lounatmaa K, Patrakka J, et al. Podocyte are firmly attached to glomerular basement membrane in kidneys with heavy proteinuria. J Am Soc Nephrol. 2004;15:2611-2618.
8. Mundel P, Shankland SJ. Podocyte biology and response to injury. J Am Soc Nephrol. 2002;13:3005-3015.
9. Kaplan J, Pollak MR. Familial focal segmental glomerulosclerosis. Curr Opin Nephrol Hypertens. 2001;10:180-187.
10. Gubler MC. Podocyte differentiation and hereditary proteinuria/ nephrotic syndromes. J Am Soc Nephrol. 2003;14:S22-S26.
11. Furness PN, Hall LL, Shaw JA, et al. Glomerular expression of nephrin is decreased in acquired human nephrotic syndrome. Nephrol Dial Transplant. 1999;14:1234-1237.
12. Wernerson A, Duner F, Pettersson E, et al. Alterated ultrastructural distribution of nephrin in minimal change nephrotic syndrome. Nephrol Dial Transplant. 2003;18:70-76.
13. Koop K, Eikmans M, Baelde HJ, et al. Expression of podocyte-associated molecules in acquired human kidney diseases. J Am Soc Nephrol. 2003;14:2063-2071.
14. Goode NP, Shires M, Khan TN, et al. Expression of α-actinin-4 in acquired human nephrotic syndrome: A quantitative immunoelectron microscopy study. Nephrol Dial Transplant. 2004;19:844-851.
15. Barisoni L, Mundel P. Podocyte biology and the emerging understanding of podocyte diseases. Am J Nephrol. 2003;23:353-360.
16. Kaplan JM, Kim SH, North KN, et al. Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nature Genet. 2000;24:251-256.
17. Michaud JL, Lemieux LI, Dube M, et al. Focal and segmental glomerulosclerosis in mice with podocyte-specific expression of mutant α-actinin-4. J Am Soc Nephrol. 2003;14:1200-1211.
18. van den Berg JG, van den Bergh Weerma MA, Assmann KJM, et al. Podocyte foot process effacement is not correlated with the level of proteinuria in human glomerulopathies. Kidney Int. 2004;66:1901-1906.
19. Meyrier A. Nephrotic focal segmental glomerulosclerosis in 2004: An update. Nephrol Dial Transplant. 2004;19:2437-2444.
20. Ly J, Alexander M, Quaggin SE. A podocentric view of nephrology. Curr Opin Nephrol Hypertens. 2004;13:299-305.
21. Nakamura T, Ushiyama C, Suzuki S, et al. The urinary podocyte as a marker for the differential diagnosis of idiopathic focal glomerulosclerosis and minimal change nephrotic syndrome. Am J Nephrol. 2000;20:175-179.
22. Li YH, Huang HC, Liu G, et al. The clinic significance of urinary podocytes in patients with focal segmental glomerulosclerosis. BeiJing DaXue XueBao YiXueBan. 2004;36:135-138.
23. Saleem MA, Ni L, Witherden I, et al. Co-localization of nephrin, podocin, and the actin cytoskeleton. Evidence for a role in podocyte foot process formation. Am J Pathol. 2002;161:1459-1466.
24. Kos CH, Le TC, Sinha S, et al. Mice deficient in α-actinin-4 have severe glomerular disease. J Clin Invest. 2003;111:1683-1690.
25. Yao J, Le TC, Kos CH, et al. α-actinin-4-mediated FSGS: An inherited kidney disease caused by an aggregated and rapidly degraded cytoskeletal protein. PLoS Biology. 2004;2:787-794.
26. Dandapani SV, Sugimoto H, Matthews BD, et al. α-Actinin-4 is required for normal podocyte adhesion. J Biol Chem. 2007;282:467-477.
27. Wagrowska-Danilewicz M, Stasikowska O, Danilewicz M. Immunoexpression of podocyte-associated proteins in acquired human glomerulopathies with nephrotic syndrome. Pol J Pathol. 2006;57:17-21.